## **Core Concept**
The question tests understanding of the immune response in graft rejection, specifically focusing on the role of major histocompatibility complex (MHC) molecules. Graft rejection is primarily mediated by the immune system recognizing the transplanted organ as foreign. The MHC molecules, also known as human leukocyte antigens (HLA) in humans, play a critical role in this recognition.

## **Why the Correct Answer is Right**
The correct answer, , refers to MHC class I and class II molecules, which are crucial for initiating an immune response against a graft. MHC molecules are responsible for presenting peptide fragments from inside the cell to T lymphocytes. If the MHC molecules on the graft are recognized as foreign by the recipient's T cells, it leads to an immune response against the graft. MHC class I molecules are expressed on almost all nucleated cells and present endogenously synthesized peptides to CD8+ T cells, while MHC class II molecules are primarily expressed on antigen-presenting cells (APCs) and present exogenously derived peptides to CD4+ T cells. The recognition of foreign MHC molecules on the graft by the recipient's immune system is a potent stimulus for T cell activation and subsequent graft rejection.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because while minor histocompatibility antigens can contribute to graft rejection, they are not the most important antigens initiating this process. Minor histocompatibility antigens are recognized by T cells in the context of self-MHC molecules and can cause graft-versus-host disease or graft rejection, but their effect is generally less potent than that of MHC antigens.
- **Option B:** This option is incorrect because ABO blood group antigens, although important for compatibility in transfusion medicine, are not the primary antigens involved in graft rejection. ABO incompatibility can lead to hyperacute rejection of a transplanted organ, but this is not the most common or important antigenic stimulus for graft rejection.
- **Option D:** This option is incorrect because while tumor antigens and other cellular antigens can be recognized by the immune system, they are not the primary initiators of graft rejection. The immune response to these antigens can be relevant in the context of cancer immunotherapy or chronic rejection processes but is not the most critical factor in acute graft rejection.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that matching MHC (HLA) types between the donor and recipient is crucial in reducing the risk of graft rejection. This is particularly important in solid organ transplantation and bone marrow transplantation. The degree of HLA matching required can vary depending on the type of transplant, but in general, a higher degree of matching is associated with a lower risk of rejection and better graft survival.

## **Correct Answer:** .